Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 16,401 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Central Nervous System Disorder Clear all

Conditions: Coma, Disorders of Consciousness, Cardiac Arrest (CA), Traumatic Brain Injuries, Ischemic Stroke, Hemorrhagic Stroke, Intracerebral, Meningitis/Encephalitis, Status Epilepticus
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Concussion, Brain
Interventions: Osteopathic Manipulative Therapy, Standard of Care Concussion Treatment; Procedure
Lead sponsor: Matthew T. Mcelroy, DO; Other
Eligibility: Up to 24 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Subarachnoid Hemorrhage, Aneurysmal, Brain Injuries, Traumatic, Cerebral Hemorrhage, Ischemic Stroke, Delayed Emergence From Anesthesia, Encephalopathy
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Stroke
Interventions: Xeomin®; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 79 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Epidural Spinal Tumors, Cancer
Interventions: Pembrolizumab, Stereotactic Body Radiation Therapy, Blood draws; Drug · Radiation · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
Interventions: Retatrutide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 204
States / cities: Alabaster, Alabama • Birmingham, Alabama • Daphne, Alabama + 159 more

Conditions: Stroke
Interventions: New Repetitive Magnetic Stimulation (rTMS) Approach, Conventional Repetitive Magnetic Stimulation (rTMS) Approach; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Traumatic Brain Injury, Post-traumatic Stress Disorder
Interventions: Telerehabilitation; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 2
States / cities: Gainesville, Florida • Tampa, Florida

Conditions: Early Alzheimer's Disease
Interventions: Semagludtide, Placebo (semaglutide); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 1,840 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 96
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 76 more

Conditions: Tourette's Disorder
Interventions: Omega-3 Fatty Acids, Olive oil; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 6 Years to 18 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Migraine
Interventions: lidocaine, bupivicaine and saline, lidocaine plus bupivicaine plus triamcinolone (steroid); Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alzheimer Disease
Interventions: Intermittent theta burst stimulation; Device
Lead sponsor: HealthPartners Institute; Other
Eligibility: 40 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Chronic Subdural Hematoma
Interventions: Memantine Hydrochloride, Placebo; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Menopause
Interventions: Probiotic, Placebo; Dietary Supplement · Other
Lead sponsor: Lallemand Health Solutions; Industry
Eligibility: 40 Years to 59 Years · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 5
States / cities: Lake Worth, Florida • Port Saint Lucie, Florida • Atlanta, Georgia + 2 more

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: Not listed
Enrollment: 1,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2011
U.S. locations: 52
States / cities: Phoenix, Arizona • Fountain Valley, California • Irvine, California + 43 more

Conditions: Traumatic Brain Injury (TBI)
Interventions: High Intensity Stepping Training, Conventional Therapy; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Headache, Migraine
Interventions: subjects personal triptan; Other
Lead sponsor: Clinvest; Other
Eligibility: 18 Years to 65 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Glioblastoma
Interventions: Distant Healing; Procedure
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2005
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stroke
Interventions: Alteplase; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Brain Metastases, Brain Metastases, Adult, Brain Cancer
Interventions: 18F fluciclovine; Drug
Lead sponsor: Baptist Health South Florida; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2033
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Stroke, Transient Ischemic Attack
Interventions: Rosuvastatin; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 30 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Stroke, Ischemic Attack, Transient
Interventions: Social incentive; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Brain Disease
Interventions: MultiHance 0.1 mmol/kg, Dotarem, MultiHance 0.05 mmol/kg; Drug
Lead sponsor: Bracco Diagnostics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Corvallis, Oregon

Conditions: Spinal Cord Injury
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Recovery Trajectory for Coma and Disorders of Consciousness

Reduction of Concussion Symptoms Through the Use of Osteopathic Manipulative Therapy

Prospective Observational Multimodal Neuromonitoring in Adult NSICU Patients

Xeomin® and Gait Related Mobility After Stroke

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

A Novel Approach for Brain Stimulation in Severe Stroke

Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

Omega-3 Fatty Acids in Tourette's Disorder

A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache

Transmagnetic Stimulation Pilot in Early Stage Alzheimer's Disease

Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)

The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health

Parkinson's Research: The Organized Genetics Initiative

Locomotor Recovery Following Traumatic Brain Injury

Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine

Efficacy of Distant Healing in Glioblastoma Treatment

Quality of Life After Stroke Using a Telemedicine-based Stroke Network

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

Rosuvastatin in African Americans With Cerebrovascular Disease

Connected Health Blood Pressure Monitoring In Stroke and TIA Patients

Crossover Comparison of MultiHance and Dotarem

Biomechanical Validation of the Transfer Assessment Instrument (TAI)